Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G McQuaker

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|March 31, 1999
Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemiaY M Zhu, L Foroni, I G McQuaker, et al.
Journal of Hematotherapy|September 15, 1998
A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collectionsC J Stainer, G Miflin, S Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefitI G McQuaker, A E Hunter, S Pacey, et al.
Bone Marrow Transplantation|July 25, 2007
Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height lossP S Maclean, A N Parker, I G McQuaker, et al.
Bone Marrow Transplantation|February 16, 2010
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation studyW A Stewart, R Pearce, K E Kirkland, et al.
Bone Marrow Transplantation|March 2, 2011
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation studyR E Protheroe, K E Kirkland, R M Pearce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot studyI G McQuaker, A P Haynes, S Anderson, et al.
Bone Marrow Transplantation|November 26, 2008
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AMLR K Malladi, A J Peniket, T J Littlewood, et al.
Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|March 31, 1999
Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemiaY M Zhu, L Foroni, I G McQuaker, et al.
Journal of Hematotherapy|September 15, 1998
A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collectionsC J Stainer, G Miflin, S Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefitI G McQuaker, A E Hunter, S Pacey, et al.
Bone Marrow Transplantation|July 25, 2007
Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height lossP S Maclean, A N Parker, I G McQuaker, et al.
Bone Marrow Transplantation|February 16, 2010
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation studyW A Stewart, R Pearce, K E Kirkland, et al.
Bone Marrow Transplantation|March 2, 2011
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation studyR E Protheroe, K E Kirkland, R M Pearce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot studyI G McQuaker, A P Haynes, S Anderson, et al.
Bone Marrow Transplantation|November 26, 2008
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AMLR K Malladi, A J Peniket, T J Littlewood, et al.
Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
Pageof 3